Related Experiment Video

Updated: May 3, 2026

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

629

Pulmonary alveolar proteinosis in adenosine deaminase-deficient mice

Rupreet Dhanju1, Weixian Min2, Cameron Ackerley3

  • 1Developmental & Stem Cell Biology Program, Hospital for Sick Children, Toronto, Ontario, Canada; Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

The Journal of Allergy and Clinical Immunology
|January 21, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.3K
Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
04:17

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

1.2K

Related Experiment Videos

Last Updated: May 3, 2026

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

629
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

10.3K
Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies
04:17

Author Spotlight: Advancing Cellular and Protein Engineering to Control Biological Functions and Develop Novel Therapies

Published on: September 27, 2024

1.2K

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48

Articles linked to this work by shared authors, journal, and citation graph.

Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency.

Immunotherapy·2026

The minor spliceosome component U4atac regulates JAK/STAT signaling to modulate hematopoiesis and immune responses in Drosophila melanogaster.

Nature communications·2026

Early identification of delayed-onset ADA deficiency: The case for expanded first-tier newborn screening.

Journal of human immunity·2026

Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).

Advances in therapy·2026

Gene alterations in inborn errors of immunity and their presence in cancers: Implications for oncogenesis, progression, and outcomes.

Human immunology·2026

Improved outcome of HSCT in STAT1 gain-of-function disease following JAK inhibition bridging.

Journal of human immunity·2025

Pumping the brakes: immune checkpoints as regulators of immunity and targets of cancer therapy.

The Journal of allergy and clinical immunology·2026

Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition.

The Journal of allergy and clinical immunology·2026

Barzolvolimab blocks SCF-enhanced IgE activation without inducing apoptosis in KIT-D816V mast cells.

The Journal of allergy and clinical immunology·2026

Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis.

The Journal of allergy and clinical immunology·2026

Cadherin-26 Contributes to Intraepithelial Eosinophil and Neutrophil Infiltration in Chronic Rhinosinusitis with Nasal Polyps.

The Journal of allergy and clinical immunology·2026

The IL-9R/Arg1 pathway promotes polyamine metabolism in human airway macrophages.

The Journal of allergy and clinical immunology·2026

Enhancing Inpatient MRI Safety and Workflow Using Standardized MRI Care Level Guidelines and Electronic Medical Record-Integrated Dashboard.

Academic radiology·2026

Medical resolution of refractory peritoneal dialysis-associated peritonitis without catheter removal.

BMJ case reports·2026

Identification of a new, likely pathogenic, heterozygous ABCB4 variant causing low phospholipid-associated cholelithiasis.

BMJ case reports·2026

Cryptococcal scleritis mimicking scleromalacia perforans.

BMJ case reports·2026

Haematopoietic stem cell transplant in a case of mucopolysaccharidosis IV with Fanconi anaemia and bone marrow failure.

BMJ case reports·2026

Innovations in the diagnosis of Pythium insidiosum keratitis: molecular advances and the path to point-of-care testing.

Expert review of molecular diagnostics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us